Precipio Competitors
| PRPO Stock | USD 27.63 0.13 0.47% |
Pair Correlation for Precipio and Intensity Therapeutics Details
Good diversification
The correlation between PRPO and INTS is -0.2, which Macroaxis classifies as Good diversification for the selected horizon. The overlap area represents the portion of risk that may be diversified away when both instruments are held together and nothing else in the portfolio changes.
Moving against Precipio Stock
The mean reversion framework for Precipio is built on the premise that markets are not perfectly efficient and that prices periodically overshoot their intrinsic value in both directions.
Precipio Competition Correlation Matrix
Correlation analysis between Precipio and its competitors helps investors understand whether diversification is real or only superficial inside the same peer group. Used correctly, correlation analysis helps separate broad industry exposure from company-specific behavior before additional capital is allocated across the peer group.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
Evaluating Precipio Stock requires separating price momentum from underlying business quality relative to competitors. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Precipio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LDDD | 0.40 | -0.20 | 0.00 | -0.40 | 0.00 | 0.00 | 13.56 | |||
| APUS | 5.98 | 0.02 | 0.00 | -0.02 | 0.00 | 12.65 | 40.97 | |||
| MODD | 5.48 | -0.43 | 0.00 | -0.45 | 0.00 | 11.76 | 65.66 | |||
| RBOT | 7.10 | -1.05 | 0.00 | -0.89 | 0.00 | 21.43 | 93.48 | |||
| PLUR | 3.08 | 0.25 | 0.06 | 0.14 | 3.48 | 9.90 | 22.62 | |||
| MLSS | 2.94 | -0.32 | 0.00 | 3.85 | 0.00 | 7.14 | 18.59 | |||
| POCI | 2.09 | 0.04 | 0.03 | -0.59 | 2.50 | 4.22 | 19.32 | |||
| STRR | 1.31 | -0.12 | 0.00 | 0.26 | 0.00 | 2.81 | 10.00 | |||
| ITRM | 5.03 | -1.01 | 0.00 | -0.46 | 0.00 | 12.50 | 66.43 | |||
| INTS | 4.19 | -0.84 | 0.00 | -0.83 | 0.00 | 9.55 | 44.33 |
Peer Comparison: Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Precipio financial statement analysis. It represents the amount of money remaining after all of Precipio operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Compare Precipio and related stocks such as Longduoduo Limited, Apimeds Pharmaceuticals, and Modular Medical Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APUS | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -1 M | -668.7 K | -777.7 K | -1.4 M | -1.3 M | -1.3 M |
| MODD | -30 K | -17.5 K | -20.8 K | -22.8 K | -31 K | -31.1 K | -106.6 K | -106.6 K | -2.5 M | -5.3 M | -7.4 M | -18.6 M | -13.9 M | -17.5 M | -18.8 M | -16.9 M | -16.1 M |
| RBOT | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -9.3 M | -12.9 M | -35.2 M | 5.2 M | -71.1 M | -63.2 M | -50.2 M | -52.7 M |
| PLUR | -77.9 K | -14.8 M | -21.2 M | -26.9 M | -24.7 M | -23.2 M | -27.8 M | -26.1 M | -35.3 M | -29.2 M | -49.9 M | -41.2 M | -28.3 M | -20.9 M | -22.6 M | -20.3 M | -21.3 M |
| MLSS | -1.9 M | -1.5 M | -870.3 K | 1.5 M | -1.7 M | -5.5 M | -5.9 M | -5.2 M | -7.4 M | -7.5 M | -7.3 M | -6.8 M | -8.7 M | -6.9 M | -4.7 M | -4.2 M | -4.5 M |
| POCI | 200 K | 961 K | -1.8 M | -1.2 M | -1.2 M | -1 M | -1 M | -351.4 K | -614.9 K | -1.4 M | -102.8 K | -928.4 K | -144.6 K | -3 M | -5.8 M | -5.2 M | -4.9 M |
| STRR | -13.5 M | -3.3 M | -4.9 M | 264 K | 2.5 M | 21.6 M | 14.3 M | -35.7 M | 736 K | -4.6 M | -6.5 M | -3 M | -5.3 M | 2.2 M | -10.4 M | -12 M | -11.4 M |
| ITRM | -13.5 M | -13.5 M | -13.5 M | -13.5 M | -13.5 M | -13.5 M | -13.5 M | -29.4 M | -77.1 M | -103.1 M | -52 M | -91.6 M | -44.4 M | -38.4 M | -24.8 M | -28.5 M | -29.9 M |
| INTS | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -5.2 M | -6 M | -7.9 M | -7.6 M | -10.5 M | -16.3 M | -14.6 M | -13.9 M |
Precipio Competitive Analysis
Precipio's competitive standing becomes clearer when measured alongside Longduoduo Company, Apimeds Pharmaceuticals, and Modular Medical. With 16.0 M in revenue and a 31.6 M market value, Precipio anchors one end of the peer spectrum. Profitability is a concern, with a -8.48% net margin and -14.76% return on equity signaling pressure on earnings. Longduoduo Company holds the larger valuation at 1.70 B versus 31.6 M. Precipio dwarfs Apimeds Pharmaceuticals on market cap at 31.6 M versus 20.4 M. Precipio converts shareholder equity more efficiently at -14.76% versus Modular Medical at -331.77%.| Better Than Average | Worse Than Peers | View Performance Chart |
Precipio Competition Peer Performance Charts
How to Analyze Precipio Against Peers
Precipio's peer analysis compares Precipio with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:- Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
- Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
- Check valuation dispersion: Review whether Precipio trades at a premium or discount versus peers and why.
- Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
- Document the thesis: Record where Precipio leads or lags and what catalysts could close or widen the gap.
Peer Comparison Metrics & Methodology
The competition view for Precipio includes correlation data, so you can see not only which peers are financially similar but also which ones move together in the market. Stronger competitive positioning is usually reflected through margins, returns on capital, and balance-sheet resilience. For peer comparison, Precipio has a market cap of 31.61 M, profit margin of -8.48%.
Reported values for Precipio are derived from periodic company reporting and market reference feeds and then standardized by Macroaxis analytics. Analyst inputs may be included when coverage is available. Refresh times depend on source availability.